BSGCT Autumn Conference


It is our great pleasure to invite you to the British Society for Gene and Cell Therapy Autumn Conference 2018 which will be held at Regents Conference & Events Centre, London on Friday 23rd November 2018.

The Autumn Conference topic will be: Genome Editing for Gene and Cell Therapy – Technologies, Models and Translation.

Gene and cell therapies have entered a very exciting area with several new treatments now licensed. There is clearly lots to talk about. Traditionally the BSGCT alternates a 3-day conference and a 1-day conference. Our 2018 Spring conference was themed “Lentiviral and other retroviral vectors in 2018” and was a great success. The Regents Conference & Events Centre was a great venue.

To accommodate the ever-growing community and scientific content we decided to deviate from the historical format slightly and will run this additional 1-day conference in 2018.

Running two 1-day conferences per year is undoubtedly an experiment, but we count on your support and very much value your feedback.  For both of the 2018 conferences we picked themes of broad interest to a large number of scientists and clinicians and hope to see many of you in November.

With best wishes

Uta Griesenbach
BSGCT President


(Click to expand)


Click the button below to register for the conference and submit your abstract. The early fee and abstract submission deadline is 24th September 2018.

Please note: We are using a new registration and abstract management system. Your previous login details will not work and you will be prompted to create a new account before you register.

Click to Register

BSGCT Conference Fees 2018 Early Fee (£) Late Fee (£)*
Academic/Public – member 110.00 165.00
Industry – member 275.00 330.00
Student – member 27.00 82.00
Undergraduate – member (free student membership) 16.00 22.00
Academic/Public – non member 192.00 258.00
Industry – non member 450.00 516.00
Student – non member 50.00 116.00
Retired BSGCT Board/Co-opted member 55.00

*Late fees start at midnight on Monday 24th September 2018
For group bookings for the BSGCT conference please contact us at


Best poster awards
BSGCT Poster Prize

CPD Accreditation
The BSGCT Annual Conference will be applying to The Royal College of Pathologists for CPD credits (excluding refreshment breaks). Certificates will be sent to all attendees upon completion of the conference evaluation form after the conference.


To submit an abstract you must first register for the conference.

Click to Register

Abstract Submission Guidelines

Make sure your abstract is in, on time and in the right format by following these simple steps:

  • The deadline for submissions is midnight on Monday 24th September 2018.
  • Your abstract should be no more than 250 words and should be in English
  • Keep your title concise and informative and only use capital letters for the beginning of a sentence or an acronym/name. DO NOT USE CAPITAL LETTERS FOR YOUR ENTIRE TITLE
  • Abstracts will be printed as submitted so they must be checked thoroughly before submission. All selected and invited abstracts are published in the conference programme book available at the registration desk during the conference, on the conference app and online in the Human Gene Therapy journal after the conference.
  • List all authors’ names in full and it is compulsory to identify a presenting author. Please note the email address supplied when you submit your abstract will be used for all correspondence pertaining to the abstract
  • Addresses should be in the following format: Group, Department/Institute, Organisation, Town/City, County/State, Country
  • Do not include acknowledgements in your abstracts – these will be included in your word count
  • Please ensure that the email provided when submitting the abstract will still be valid in October when the abstract notification is emailed
  • You must register as a delegate for the conference to present your poster or oral presentation. The programme will be updated as presenters are confirmed
  • If you have been selected for an oral presentation of 15 minutes this should be 10 minutes + 5 minutes for questions please.

Poster Guidelines

  • You will need to hang your poster before the conference starts (9am on Friday 23rd November 2018) and take it down by the end of the afternoon tea break. We cannot take responsibility for any posters left after this time.
  • Posters should be made in portrait orientation, maximum size 110cm high, 80cm wide (NB: this is slightly smaller than AO). If your poster does not match these dimensions we cannot guarantee that it will fit the poster boards.
  • Each poster will be allocated a display number which will be given to you on the day. You will be given 4 pieces of Velcro of size approximately 2cm each to attach your poster to the board when you come to the registration desk on arrival.
  • The posters will be judged on Friday 23rd November 2018 (all even numbers 12:15-12:45, all odd numbers 12:45-13:15). We recommend that you are by your poster to answer questions etc. during these times. Prizes will be awarded in the last session before the networking drinks.

If you have any queries please contact


Please see our partnership prospectus below which is intended to start the ball rolling with some ideas. Once you have had a look, please contact us at for more information or to discuss your requirements and objectives in more detail.

View Partner Pack

Confirmed Sponsors


Boehringer Ingelheim
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals.


Miltenyi Biotec Ltd.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.


Oxford BioMedica
Using our unique LentiVector® delivery platform, we have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. We have strong partnerships with Novartis, Bioverativ (part of the Sanofi group), Immune Design, Boehringer Ingelheim/UK Cystic Fibrosis Gene Therapy Consortium and Orchard Therapeutics, providing them with access to our intellectual property, state-of-the-art production facilities and expertise, and, in addition, we have licensed products and technology rights to Sanofi and Axovant. These partnerships provide us with multiple income streams, consisting of upfront milestone payments, development and production fees and potential royalties on future product sales. We plan to progress our wholly-owned products via spin-outs and out-licensing opportunities, while continuing to invest in our LentiVector® platform. We plan to continue our preclinical R&D to discover new potential products.


Envigo provides essential research services, models and products for biopharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. Our business is founded on a dedication to customer service and the expertise and experience of our 3,800 people. With over 50 locations worldwide we are committed to helping customers realize the full potential of their research and products as we work together to build a healthier and safer world.


Oxford Genetics
Oxford Genetics mission is the creation of transformative systems and services to aid in the discovery and development of biologics, cell and gene therapies.
A unifying theme across the portfolio is expertise in designing DNA and using this to optimise the expression of proteins, improving viral delivery systems and cell line engineering. Founded in 2011, Oxford Genetics is headquartered in Oxford, UK. Its products are sold directly and through a global network of distributors.



Cobra Biologics
Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.
Cobra has two GMP approved facilities in Sweden and the UK, each with specific expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.
As a trusted provider and a key partner in the drug development and commercialisation process, we take pride in our manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries.
Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.
For more information, or to get in touch with our team, visit:


PlasmidFactory GmbH & Co. KG
‘The better way to DNA’

PlasmidFactory GmbH & Co. KG is a CMO in the Gene and Cell Therapy field, founded in 2000 in Bielefeld, Germany. It has since developed into an international company. In addition to custom manufacturing of plasmid and minicircle DNA in different Quality Grades (Research up to GMP), PlasmidFactory focuses its research and development efforts on its core competencies in the production, analysis, application, and storage of plasmid and minicircle DNA.
+49 (0) 521 299 735 0


Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. We offer an unmatched combination of innovative technologies and services to enable our customers to make the world healthier, cleaner and safer.

INTEGRA Biosciences Ltd
Since 1965, INTEGRA has been dedicated to developing solutions for pipetting and media preparation, fulfilling the needs of our customers in research, diagnostics and quality control. It is our passion to work side by side with our customers to understand their problems and answer their needs with innovative products. In order to do this, we maintain our own sales and support organizations in the USA, Canada, China, UK, France, Germany, Austria and Switzerland, as well as a network of over 100 highly trained distribution partners worldwide.
We manufacture instruments and plastic consumables of outstanding quality as well as developing new and technologically advanced range of handheld pipettes, which are simple to use and meet the ergonomic needs of our customers. Today we are proud to offer the widest product line of pipettes in the market, spanning a range from single channel mechanical pipettes up to 384 channel electronic bench-top instruments.

PeproTech is a privately owned biotechnology company focusing on the development and manufacture of high quality cytokine products for the life-science and cell therapy market.
Our mission is to provide the highest quality products to support the needs of today’s scientists and researchers.
Please contact: 020 7610 3062 or

Proteintech: Antibodies | ELISA Kits | Proteins
Founded by scientists in 2001, Proteintech understands the importance of products with high specificity and reproducibility. With this in mind, Proteintech manufacture and validate every product in-house. In its catalogue of antibodies against 12,000 targets, human-cell expressed cytokines and ELISA kits, Proteintech ensures all validation data is made available to the researcher along with 24 hour expert technical support. For more information, please visit

VectorBuilder is a revolutionary platform for all your custom vector designing, cloning, BAC modification, shRNA/CRISPR library and virus packaging needs. Our massive collection of vector backbones, promoters and ORFs ensures that we generate your vectors at a fraction of the cost and time that you would spend doing it yourself. Our online platform provides a highly intuitive work flow for you to design your desired vectors with just a few mouse clicks and then purchase the custom cloning of your designed vector. To date, we have delivered over 160,000 vectors and viruses. VectorBuilder truly is the next step in the evolution of cloning.

Lonza Cologne GmbH
Nattermannallee 1
Koeln, 50829
Phone: +49-221-99199-0
Fax: +49-221-99199-111


Lonza provides the pharma market with the tools that life-science researchers use to develop and test therapeutics, beginning with basic research stages on to the final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research to quality control tests and software that ensures product quality. Lonza Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies. The company delivers physiologically relevant cell biology solutions and complete solutions for rapid microbiology.





To help you get the best special offers at nearby hotels Regent’s Conferences & Events have put together a HotelMap that shows the nearby accommodation options and best possible rates and special offers.

The map displays live availability and allows you to book directly with each hotel. BSGCT provides this as information for delegates only. BSGCT cannot comment on the quality of the service provided by the various establishments listed.

The BSGCT Autumn 2018 Conference HQ Hotel is: The Meliá White House Hotel. To book a room as a delegate at this hotel please download and follow instructions on the form HERE.

Travel Information

Venue Address:
Regent’s Conferences & Events, Regent’s University London, Inner Circle, Regent’s Park, London, NW1 4NS

By Underground
Take the London Underground (Tube) to Baker Street station which is closest station to the venue. To help you plan your journey, click here to use the Journey Planner on the Transport for London website.

From Baker Street Station
Take the Marylebone Road exit. Walk past Madame Tussauds and take the first road on your left, York Gate. Follow the road into Regent’s Park and over the bridge; you will see the main entrance to the University on your left-hand side. This walk will take approximately 10 minutes.

By Road
When arriving in central London, take the A501 (Marylebone Road) and turn into York Gate. Cross York Bridge and you will find Regent’s University on your left-hand side. Parking information.

From London Heathrow Airport
Heathrow Express train service to Paddington station. London Underground from Paddington to Baker Street station. Total journey time approximately 35 minutes.

From London Gatwick Airport
Gatwick Express train service to Victoria station. London Underground from Victoria to Baker Street station. Total journey time approximately 60 minutes.

From London City Airport
Docklands Light Railway (DLR) to Canning Town station. London Underground from Canning Town to Baker Street station. Total journey time approximately 45 minutes.

From St Pancras International, home to the Eurostar
London Underground from King’s Cross St Pancras to Baker Street station. Total journey time approximately 10 minutes.